首页> 美国卫生研究院文献>The Mental Health Clinician >Implementation of a QTc-interval monitoring protocol by pharmacists to decrease cardiac risk in at-risk patients in an acute care inpatient psychiatric facility
【2h】

Implementation of a QTc-interval monitoring protocol by pharmacists to decrease cardiac risk in at-risk patients in an acute care inpatient psychiatric facility

机译:药剂师实施QTc间隔监测方案以降低急诊住院精神病院中高危患者的心脏风险

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionMany medications commonly prescribed in psychiatric hospitals can cause QTc-interval prolongation, increasing a patient's risk for torsades de pointes and sudden cardiac death. There is little guidance in the literature to determine when an electrocardiogram (ECG) and QTc-interval monitoring should be performed. The primary end point was improvement of the appropriateness of ECGs and QTc-interval monitoring of at-risk psychiatric inpatients at Barnabas Health Behavioral Health Center (BHBH) and Monmouth Medical Center (MMC) following implementation of a standardized monitoring protocol. The secondary end point was the number of pharmacist-specific interventions at site BHBH only.
机译:简介精神病医院通常使用的许多药物会导致QTc间隔延长,从而增加患者发生尖端扭转型室速和心源性猝死的风险。在文献中几乎没有指导来确定何时应该执行心电图(ECG)和QTc间隔监测。主要终点是在实施标准化监测方案后,对巴纳巴斯健康行为健康中心(BHBH)和蒙茅斯医学中心(MMC)的高危精神病患者进行ECG监测和QTc间隔监测的适当性得到改善。次要终点是仅在BHBH站点进行的药剂师特定干预的数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号